Publications by authors named "Jared Head"

Claim this Profile
E
Engineering a Bright Near-Infrared Fluorescent Protein by Screening a Comprehensive Phenotypic Landscape.
Devon L Kulhanek, Qiyao Wei, Jared Head, Jessica Hellinger, Zach Jansen

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Pot Dual-Wavelength 3D Printing Breaks Free from Support Constraints.
Jared Cason Head, Syed Muhammad Usama

ACS Cent Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors" [Bioorgan. Med. Chem. Lett. 50 (2021) 128352].
Yufang Xiao, Bayard R Huck, Ruoxi Lan, Lizbeth DeSelm, Xiaoling Chen, Jared Head

Bioorg Med Chem Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Covalent Bruton's Tyrosine Kinase Inhibitors with Decreased CYP2C8 Inhibitory Activity.
Hui Qiu, Zahid Ali, Julian Bowlan, Richard Caldwell, Anna Gardberg, Jared Head

ChemMedChem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors.
Yufang Xiao, Bayard R Huck, Ruoxi Lan, Lizbeth DeSelm, Xiaoling Chen, Jared Head

Bioorg Med Chem Lett· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitors.
Hui Qiu, Zahid Ali, Andrew Bender, Richard Caldwell, Yi-Ying Chen, Jared Head

Bioorg Med Chem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases.
Richard D Caldwell, Hui Qiu, Ben C Askew, Andrew T Bender, Nadia Brugger, Jared Head

J Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
Philipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, Ngan Nguyen, Federica Morandi, Jared Head

J Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Affinity-Based Probes for Btk Occupancy Assays.
Hui Qiu, Richard Caldwell, Lesley Liu-Bujalski, Andreas Goutopoulos, Reinaldo Jones, Jared Head

ChemMedChem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors.
Hui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, Ariele Viacava Follis, Anna Gardberg, Jared Head

Bioorg Med Chem Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk.
Richard Caldwell, Lesley Liu-Bujalski, Hui Qiu, Igor Mochalkin, Reinaldo Jones, Jared Head

Bioorg Med Chem Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit.
Hui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, Ariele Viacava Follis, Anna Gardberg, Jared Head

Bioorg Med Chem Lett· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling.
Andrew T Bender, Anna Gardberg, Albertina Pereira, Theresa Johnson, Yin Wu, Jared Head

Mol Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Btk inhibition treats TLR7/IFN driven murine lupus.
Andrew T Bender, Albertina Pereira, Kai Fu, Eileen Samy, Yin Wu, Jared Head

Clin Immunol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder.
Oscar Gary Bukstein, Jared Head

Expert Opin Pharmacother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis